期刊文献+

C-erb-B4/HER4国内外研究进展 被引量:4

下载PDF
导出
摘要 C-erb-B4/HER4是表皮生长因子家族中的一员。最新研究发现HER4与人类肿瘤密切相关,甚至有些人认为HER4就是某些肿瘤的相关基因。现综述HER4与人类肿瘤发生、发展、诊断、治疗和预后的研究进展。
出处 《黑龙江医药》 CAS 2010年第5期804-805,共2页 Heilongjiang Medicine journal
  • 相关文献

参考文献17

  • 1Normanno N,Bianco C,Strizzi L,et al.The ErbB receptors and their ligands in cancer:an overview[J].Curr Drug Targets,2005,6:243-57.
  • 2Lai C,Lemke G.An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system[J].Neuron,1991,6:691-704.
  • 3Plowman GD,Culouscou JM,Whitney GS,et al.Ligand-specific activation of HER4/ pl80erbB4,a fourth member of the epidermal growth factor receptor family[J].Proc Natl Acad Sci USA,1993,90(5):1746-50.
  • 4Zimonjie DB,AlimandiM,MikiT,et al.Localizationofthehuman HER4/erbB-4 gene toehromosomez[J].Oncogene,1995,10:1235-7.
  • 5Sian M Tovey,Barbara Dunne.HER4 in breast cancer:comparison of antibodies against intra and extra-cellular domains of HER4[J].Breast Cancer Research,2006,8:1186-394.
  • 6Frank E.Jones.HER4 extracellular domain(4ICD)Activity in the Developing Mammary Gland and Breast Cancer[J] J Mammary Gland Biol Neoplasia,2008,13(2):247-58.
  • 7Merimsky O,Kollender Y,Issakov J,et al.Induction chemotherapy for born Sarcoma in adults:correlation of results with erbB-4 expression[J].Oncol ReP,2003,10:1593-9.
  • 8Andrea Sassen,Justine Rochon,Cytogenetic analysis of HER1/EGFR,HER2,HER3,HER4 in 278 breast cancer patients[J].Breast Cancer Research 2008,10,1186-843.
  • 9Fenghua Zeng,Ming-Zhi Zhang.ErbB4 Isoforms Selectively regulate Growth Factor-induced Madin-Darby Canine Kidney Cell Tubulogenesis[J].Molecular Biology of the Cell,2007,18:4446-7.
  • 10王劲松,王深明,黄雪玲,李晓曦,陈国锐.c-erbB-2、c-erbB-4原癌基因蛋白表达与乳腺癌发生的相关关系[J].中华实验外科杂志,1998,15(5):407-409. 被引量:9

二级参考文献51

  • 1葛棣,冯明祥,曾亮.表皮生长因子受体家族在食管癌中表达的临床研究[J].中国临床医学,2004,11(5):717-720. 被引量:11
  • 2陈艺华.癌基因、抗癌基因异常与人乳腺癌[J].中华病理学杂志,1994,23(2):122-124. 被引量:12
  • 3Starr A, Greif J, Vexler A, et al. ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anticancer therapy[J]. Int J Cancer,2006 Jul 15,119(2):269.
  • 4al- Moustata AE, Alaoui- Jamali M, Paterson J, el al. Expression of P185erbB- 2, P160ERBb - 3, P180erbB - 4, and Heregulin alpha in bumyan normal bronchial epithelial and lung cancer cell lines [ J ].Anticancer Res, 1999,19(1A) :481.
  • 5Srinivasan R, Poutsom R, Hurst HC, et al. Expression of tile e- erbB - 4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid turnout types[ J]. J Pathol, 1998,185 (3) : 236.
  • 6Li W, Park JW, Nuijens A, et al. Heregulin is rapidly translocated to the nueleus and its transprot is correlated with e - mye induction in breast cancer cells[J]. Oncogene, 1996, 12( 11 ) :2473 - 2477.
  • 7Junttila TT, Sundvall M, Lundin M, et al. Cleavable ErbB4 isofonn in estrogen reeeptor - regulated growth of breast cancer cells [J]. Cancer Res,2005 Feb 15,65(4) : 1384.
  • 8Kountourakis P, Pavlakis K. Psyrri A, et al. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas [J]. BMC Cancer,2006 Feb 28,6:46.
  • 9Jacobs TW, Gown AM, Yaziji H, et al. Specificity of hercep test in determing Her-2/neu status of breast cancers using the United States Food and Drug Administration - approved scoring system [ J ]. J Clin Oncol, 1999,17 (7) : 1983 - 1987.
  • 10Plowman GD,Culouscou JM, Whitney GS,et al. Ligand-specific activation of HER4/P180erbB4, a fourth member of the epidermal growth factor receptor family [ J ]. Proc Natl Acad Sci USA, 1993,90 ( 5 ) :1746 - 1750.

共引文献28

同被引文献31

  • 1朱安义,史子敏,周燕玉,李里香,潘正跃,黄红卫,邹高德.表皮生长因子受体在膀胱癌非肿瘤黏膜中的表达及意义[J].中华泌尿外科杂志,2006,27(S1):43-45. 被引量:8
  • 2蔡昌豪,杨少波,吴本俨,吴道宏,王孟薇.多原发癌组织中bcl-2表达状况的研究[J].中华老年多器官疾病杂志,2004,3(4):296-296. 被引量:3
  • 3杨少波,蔡昌豪,吴本俨,吴道宏,王孟薇.消化道多原发癌组织中凋亡相关蛋白p53和bcl-2的表达[J].现代肿瘤医学,2005,13(2):180-181. 被引量:8
  • 4康元上,孙丹宁,王勤,李靖,蒙明森,孙道冬,舒勇,颜加强.膀胱癌组织中PCNA、c-erbB2、bcl-2和p53蛋白表达及其临床意义[J].临床泌尿外科杂志,2007,22(5):385-387. 被引量:5
  • 5HAYAT M J, HOWLADER N, REICHMAN M E, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program[J]. Oncologist, 2007,12(1) :20-37.
  • 6CALDERWOOD A H, HUO D, RUBIN D T. Asso- ciation between colorectal cancer and urologic cancers [J]. Arch Intern Med, 2008,168(9):1003-1009.
  • 7VAINRIB M, LEIBOV1TCH I. Urological implica- tions of concurrent bladder and lung cancer[J]. Isr Med Assoc J, 2007, 9(10):732-735.
  • 8CHUANG S C, HASHIBE M, SCELO G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer regis- tries[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(6) : 1543- 1549.
  • 9RAMMEH2ROMMANI S, ZERMANI R, SFAXI M, et al. Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bel2 in the su- perficial tumors of the bladder[J]. Tunis Med, 2007, 85(6) :509-512.
  • 10IZQUIERDO L, MENGUAL L, GAZQUEZ C, et al. Molecular characterization of upper urinary tract tumours[J]. BJU Int, 2010,106(6) :868-872.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部